5.27
-1.31%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Anhui Fengyuan Pharmaceutical Co
Its shares trade on Shenzhen under the ticker 000153.SZ. It has been listed since 20 September 2000. In the fiscal year to 31 December 2025, it reported revenue of CN¥3.86bn and net income of CN¥99.4m. At that date it held total assets of CN¥5.06bn and shareholders' equity of CN¥2.10bn.
Anhui Fengyuan Pharmaceutical Co., Ltd. engages in the pharmaceutical manufacturing and drug retail distribution business. The company is headquartered in Hefei, Anhui. The company went IPO on 2000-09-20. The firm's products mainly include antipyretic and analgesic, women and children, the nervous system, cardiovascular, urinary system, nutrition, antibiotics and active ingredient and other products. The firm is also engaged in the retailing and wholesale of drugs. The firm conducts its businesses mainly in domestic markets, with Anhui province as its main market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 20 Sept 2000
- Employees
- 4,654
- Website
- bbcayy.com ↗
Leadership
Pay as last reported
- Mr. Jun LiChief Financial Officer
- Mr. Jiahe LuGeneral Manager
- Yue'e HuDeputy General Manager, Director, since 2007CN¥213,200
- Zixue ZhouDeputy General Manager, Director, since 2007CN¥219,200
- Guokun LiDeputy General ManagerCN¥213,200
- Xudong XunDeputy General Manager, since 2010CN¥214,500
- Shaoyi ZhangExecutive Deputy General ManagerCN¥248,200
- Ms. Yuping ZhangDeputy General Manager
- Mr. Jun ZhangSecretary of the BoardCN¥114,600
- Li DuDirector
- Mr. Hongman HeDirector
- Guangwei HeIndependent DirectorCN¥30,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Anhui Fengyuan Pharmaceutical employs 4,654 full-time employees in Hefei, China.
- The company's product portfolio includes antipyretic and analgesic drugs and women and children medications.
- Anhui province serves as the main market for Anhui Fengyuan Pharmaceutical's domestic business operations.
Weaknesses
- The company's business is primarily focused on the domestic market in Anhui province.
- Anhui Fengyuan Pharmaceutical has no international market presence beyond China.
- The firm's product range lacks diversity in the cardiovascular and urinary system segments.
Opportunities
- Expanding into the Chinese pharmaceutical market for cardiovascular and urinary system products.
- Increasing retail drug distribution in Anhui province's growing population.
- Developing new active ingredient products for the domestic pharmaceutical market.
Threats
- Competition from other domestic pharmaceutical companies in Anhui province.
- Regulatory changes in China's pharmaceutical industry affecting drug manufacturing.
- Economic downturns impacting domestic pharmaceutical demand in China.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.